Ms Sarah Meibusch

Sarah Meibusch is a motivated, high achieving life science leader based in Brisbane, Australia. She is currently a Partner at one of Australia’s largest venture capital firms, OneVentures. In this role, she is responsible for sourcing life sciences companies and actively shaping their future. She applies her global executional experience and entrepreneurial passion to nurture their success. Her enterprise level leadership experience has been forged over 20 years in a wide spectrum of organisations, including start-up, private companies, ASX and NASDAQ-listed companies, a multi-national pharmaceutical company and university research organisations.

Sarah has a breadth of experience across both human health and agriculture from a career that has straddled both sectors with a deal sheet of high value IP rich asset transactions. Prior to OneVentures, she was the Asian Business Development lead for Shire Pharmaceuticals (now Takeda), a global specialty pharmaceutical company. Sarah identified technologies and developed collaborations across Japan, Korea, Australia, New Zealand, Singapore and Taiwan including playing a key role in sourcing the $300M Fibrotech deal announced in 2015. Sarah has a strong operational understanding of the life science industries gained through senior management roles at the Progen Pharmaceuticals, The University of Queensland’s QAAFI institute, Beef CRC and Pyxis Genomics.